The autism therapy industry segment may see a bounceback in dealmaking in the not-so-distant future.
After reaching a fever pitch in 2019, the number of deals has trended downward, with 2022 seeing several high-profile stumbles of major platform companies, inflation, rising interest rates and workforce challenges. However, several industry insiders attending the Autism Investor Summit tell Behavioral Health Business that these challenges have lessened to the point that dealmaking in the space could soon pick up again.
All the while, the factors that made autism therapy a desirable investment target remain. Many see it as one of the most attractive places in health care to make investments, reports Behavioral Health Business. Read more.
